Search Tag: nucleosomics technology

Executive Health Management

Volitionrx-and-university-hospital-bonn-collaborate-on-cancer-diagnostic-test-evaluation

2014 25 Apr

The agreement includes CE Mark performance evaluation and doubles the Hospital’s prospective trial of 20 cancers, adding a range of additional vital background work   VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, has announced that VolitionRx has extended its agreement...Read more